This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of RABAVERT rabies vaccine with diluents. The award, valued at $47,426.00, is a Firm Fixed Price Delivery Order that will run through November 19, 2024. The contract does not have a set-aside designation, indicating open competition.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific award is likely a delivery order against that larger IDC contract, enabling efficient government procurement of critical medical commodities including specialty medications, vaccines, and other essential healthcare products.
Generated 2/17/25, 9:44 PM